Clinical Trials Directory

Trials / Completed

CompletedNCT03981809

Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

Development and Validation of a Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors With Persistent Pain

Status
Completed
Phase
Study type
Observational
Enrollment
92 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Development and internal validation of an easy-to-use tool for clinical pain assessment. The tool has to be applicable in any clinical practice and without the need for expensive and complicated hospital tools to identify the source of persistent pain after the treatment of cancer.

Detailed description

An adequate selection of physiotherapy treatment for persistent pain after the treatment of cancer, depends highly on the mechanism of the pain. Pain can arise from a damaged nerve or tissue (skin, lymphatic system...). But when pain becomes chronic, alterations to the central nervous system can occur, as regulations of the facilitating and inhibiting mechanisms. These alterations may cause central sensitization pain. The body is now sensitized and cannot distinct harmful from harmless stimuli. Each type of pain requires a specific treatment, therefore identification of the pain mechanism is crucial. Up till now, expensive and complex tests were performed in a hospital setting to determine if a patient suffers from neuropathic, nociceptive or central sensitization pain. This study aims for developping an assessment tool that does not require expensive devices but can be easily performed by any physiotherapist, within the timeframe of a standard consultation.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnostic test ("PainsCan") for the identification of the dominant pain mechanisms in cancer survivers with persistent painEasy-to-use screening tool to identify the dominant pain mechanism by using quick clinical tests and compare their accuracy and validity with complicated reference tests.

Timeline

Start date
2019-06-13
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2019-06-11
Last updated
2023-08-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03981809. Inclusion in this directory is not an endorsement.